Literature DB >> 7817129

Hepatotoxicity in guinea pigs following acute inhalation exposure to 1,1-dichloro-2,2,2-trifluoroethane.

G B Marit1, D E Dodd, M E George, A Vinegar.   

Abstract

Groups of 10 male Hartley guinea pigs were exposed to 3.0, 2.0, 1.0, or 0.1% (v/v) 1,1-Dichloro-2,2,2-trifluoroethane (HCFC-123) or 1.0% (v/v) halothane by inhalation for 4 hr. A sixth group of 10 guinea pigs received only air. All animals were sacrificed 48 hr postexposure. Gross and histopathologic examination of the liver, heart, and kidney and routine hematology and clinical chemistry analyses [including isocitrate dehydrogenase (ICDH)] were done on all guinea pigs. Lesions related to HCFC-123 and halothane exposure were limited to the liver and included centrolobular vacuolar (fatty) change, multifocal random degeneration and necrosis, and centrolobular degeneration and necrosis. These lesions were observed in 90-100% of the exposed animals and were absent in the air-only controls. There was significant individual animal variation in susceptibility to both HCFC-123 and halothane, resulting in a spectrum of histologic lesions and clinical chemistry values within each exposure group. Alanine aminotransferase, aspartate aminotransferase, and ICDH were the most significant predictors of hepatocellular damage. Similarities in the response between halothane and HCFC-123 in this guinea pig model suggests that humans susceptible to halothane-induced hepatitis may be susceptible to HCFC-123 by a common mechanism of toxicity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7817129     DOI: 10.1177/019262339402200406

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  2 in total

1.  HCFC-123-induced toxic hepatitis and death at a Korean fire extinguisher manufacturing facility: a case series.

Authors:  Mu Young Shin; Jong Soo Park; Hae Dong Park; Jihye Lee
Journal:  Ann Occup Environ Med       Date:  2018-03-28

2.  Exposure Assessment for Toxic Hepatitis Caused by HCFC-123.

Authors:  Ki-Woong Kim; Hae Dong Park; Konghwa Jang; Jiwon Ro
Journal:  Saf Health Work       Date:  2018-05-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.